ADCY5-related dyskinesia: a case report.

Neurol Res Pract

Department of Neurology, Kaohsiung Chang Gung Memorial Hospital, Niaosung District, 123 Dapi Road, Kaohsiung, 83301, Taiwan.

Published: August 2022

Adenylyl cyclase 5 (ADCY5) related dyskinesia is a rare disorder characterized by early-onset paroxysmal choreoathetosis, dystonia, myoclonus, or a combination of the above, which primarily involved the limbs, face, and neck. Other common clinical features are axial hypotonia and episodic exacerbation of dyskinesia. Both sporadic and inherited cases have been reported and the predomiant mode of inheritance is autosomal dominant. Herein, we describe the first ADCY5-related dyskinesia patient in Taiwan.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9377057PMC
http://dx.doi.org/10.1186/s42466-022-00204-wDOI Listing

Publication Analysis

Top Keywords

adcy5-related dyskinesia
8
dyskinesia case
4
case report
4
report adenylyl
4
adenylyl cyclase
4
cyclase adcy5
4
adcy5 dyskinesia
4
dyskinesia rare
4
rare disorder
4
disorder characterized
4

Similar Publications

Sleep and circadian rhythm dysfunctions in movement disorders beyond Parkinson's disease and atypical parkinsonisms.

Curr Opin Neurol

August 2024

Chulalongkorn Center of Excellence for Parkinson's Disease & Related Disorders, King Chulalongkorn Memorial Hospital, The Thai Red Cross, Department of Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.

Article Synopsis
  • This review focuses on how sleep and circadian rhythm issues occur in various hyperkinetic movement disorders, not just Parkinson’s disease, including conditions like tremor, dystonia, and tics.
  • Common sleep problems identified in these disorders include insomnia, poor sleep quality, excessive daytime sleepiness, and REM sleep behavior disorder, particularly noted in conditions like Wilson’s disease and spinocerebellar ataxia.
  • It emphasizes the need to consider the impact of medications on sleep issues, and how specific symptoms can help differentiate between movement disorders when diagnosing.
View Article and Find Full Text PDF

The nine different membrane-anchored adenylyl cyclase isoforms (AC1-9) in mammals are stimulated by the heterotrimeric G protein, Gα, but their response to Gβγ regulation is isoform specific. In the present study, we report cryo-electron microscope structures of ligand-free AC5 in complex with Gβγ and a dimeric form of AC5 that could be involved in its regulation. Gβγ binds to a coiled-coil domain that links the AC transmembrane region to its catalytic core as well as to a region (C) that is known to be a hub for isoform-specific regulation.

View Article and Find Full Text PDF

Introduction: ADCY5-related dyskinesia is a rare neurological disease caused by mutations in the gene encoding the adenylyl cyclase 5 (ADCY5) isoform, a protein that plays an important role in intracellular transmission. Variants in ADCY5 are associated with a spectrum of neurological disease encompassing dyskinesia, chorea, and dystonia. State of the-art.

View Article and Find Full Text PDF

Unlabelled: In this case study, we report the case of a 13-year-old girl with citrullinemia type 1 (MIM #215700), an autosomal recessive inherited disorder of the urea cycle, which was confirmed by the identification of a homozygous pathogenic variant in the argininosuccinate synthetase 1 () gene. However, the patient presented abnormal hyperkinetic movements with global developmental delay and clinical signs that were not fully consistent with those of citrullinemia type 1 or with those of her siblings with isolated citrullinemia type 1. Exome sequencing showed the presence of a heterozygous pathogenic variant in the adenylate cyclase type 5 () gene.

View Article and Find Full Text PDF

Background: Adenylyl cyclase 5 (ADCY5)-related movement disorder (ADCY5-RMD) is a rare, childhood-onset disease resulting from pathogenic variants in the gene. The clinical features, diagnostic options, natural history, and treatments for this disease are poorly characterized and have never been established through a structured approach.

Objective: This scoping review attempts to summarize all available clinical literature on ADCY5-RMD.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!